CYC

CYCLOPHARM FPO [CYC]
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.
Healthcare · ASX Small Cap
$0.5500 -1.8%

Updated 23 Jul 2026 · Signals refresh every scan

Get alerts when CYC triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track CYC — Free

Active Signals

Bullish Signals

  • Watch out — volume is flowing out even as price holds up. Distribution pattern
  • Drifting lower — down 4.3% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
  • Volume-price trend suggests distribution — sellers may be sneaking out while price holds
  • Critical cash runway (1.5 quarters)
  • Low P/S ratio (2.2x)
  • Moderate revenue growth (+10%)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (13% of range)
  • Small-cap ($20-100M)
  • CANSLIM S: Tight float (49%)
  • CANSLIM I: Institutional ownership (25%)
  • Sentiment is mixed — no strong consensus either way
  • Beneish M-Score -0.29 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Deeply negative margins (-53%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 40% over the past year
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.70%/day)
Ask Scout AI about CYC
"What's driving CYC today?" "How does CYC compare to peers?" "Key risks for CYC?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Immediate 11-Site Technegas Rollout at University Hospitals
NONE Notification of cessation of securities - CYC
NONE CYC First-Half 2026 Update

Recent ASX Announcements

2026-07-14 Immediate 11-Site Technegas Rollout at University Hospitals PRICE SENSITIVE
2026-07-06 Notification of cessation of securities - CYC
2026-07-02 CYC First-Half 2026 Update PRICE SENSITIVE
2026-06-25 Change in substantial holding

Key Metrics

$70.4M
Market Cap
139K
Avg Volume
0.8x
Vol Ratio
$0.45 — $1.29
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-49.3%
ROE
-53.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 49%
LLeader vs LaggardlaggardRS: -16
IInstitutional SponsorshippassInst: 25%
MMarket DirectionneutralNeutral

Sector: Healthcare

102 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
PIQ +23.3%SLD -18.1%ADR -17.9%IDT -17.1%VBS -14.3%
Compare:CYC vs PIQCYC vs SLDCYC vs ADR
Scout Pro — Deeper Analysis for CYC
Try Pro free for 30 days
Share this analysis

Track CYC and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required